Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse events
about
P2860
Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse events
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@ast
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@en
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@nl
type
label
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@ast
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@en
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@nl
prefLabel
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@ast
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@en
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@nl
P2093
P2860
P1476
Mephenytoin as a probe for CYP ...... d occurrence of adverse events
@en
P2093
B Oosterhuis
J H Jonkman
L F de Leij
R A de Zeeuw
W J Tamminga
P2860
P356
10.1046/J.1365-2125.2001.01331.X
P407
P577
2001-05-01T00:00:00Z